Recall Notices
Clonazepam Orally Disintegrating Tablets Recall
November 22, 2024
On Nov. 19, 2024, Endo Pharmaceuticals, the parent company of Par Pharmaceuticals, notified the FDA of an expansion of its voluntary recall of Clonazepam Orally Disintegrating Tablets
Cinacalcet Recall
October 30, 2024
On Oct. 9, 2024, Dr. Reddy’s recalled all lots and expiration dates for cinacalcet 30mg, 60mg and 90mg tablets.
Veklury Recalled
October 08, 2024
On Sept. 20, 2024, Gilead Sciences recalled one lot of Veklury® (remdesivir) for injection 100mg/vial.
Atovaquone Recalled
October 08, 2024
On Sept. 17, 2024, Bionpharma Inc. recalled one lot of Atovaquone Oral Suspension because it was found to be contaminated with the bacteria Cohnella.
Medical Device Correction for FreeStyle Libre 3 Sensors
September 16, 2024
On July 24, 2024, Abbott Diabetes Care, Inc. issued a medical device correction for FreeStyle Libre 3 Sensors because they can give an incorrectly high glucose reading, posing a potential health risk for people with diabetes.
Sodium Chloride Recalled
August 02, 2024
On July 24, 2024, B. Braun Medical Inc. recalled two lots of sodium chloride (NaCl) injection 0.9% 1000mL – E8000.
Clonazepam Recalled
July 24, 2024
On July 9, 2024, Endo USA, Inc. recalled Clonazepam 0.125mg and 0.25mg Orally Disintegrating tablets (ODT) from a single lot due to a packaging error.
Potassium Chloride Extended Release Capsules Recalled
July 01, 2024
On June 25, 2024, Glenmark Pharmaceuticals, Inc. recalled numerous lots of potassium chloride extended-release 750mg capsules from the consumer level.
The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.